Evidence map›Paper›PMID 25183306›Full record

ArticleHeart and vessels2016

Long-term prognostic impact of the attenuated plaque in patients with acute coronary syndrome.

Hiroyuki Okura, Toru Kataoka, Minoru Yoshiyama, Junichi Yoshikawa, Kiyoshi Yoshida

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Hiroyuki OkuraThe Division of Cardiology, Bell Land General Hospital, Sakai, Japan. hokura@fides.dti.ne.jp.
Toru KataokaThe Division of Cardiology, Bell Land General Hospital, Sakai, Japan.
Minoru YoshiyamaThe Division of Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Junichi YoshikawaThe Division of Internal Medicine and Cardiology, Nishinomiya Watanabe Cardiovascular Center, Nishinomiya, Japan.
Kiyoshi YoshidaThe Division of Cardiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
Berurando General Hospital · JPHyogo Brain and Heart Center · JPKawasaki Medical School · JPOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several intravascular ultrasound studies have reported that culprit lesion-attenuated plaque (AP) is related to slow flow/no reflow after percutaneous coronary intervention (PCI). Long-term prognostic impact of the AP is unknown. The aim of this study was to investigate acute and long-term clinical impact of the AP in patients with acute coronary syndrome (ACS). A total of 110 ACS patients who underwent successful PCI were enrolled. Acute and long-term clinical outcomes were compared between patients with AP (AP group: n = 73) and those without AP (non-AP group: n = 37). Long-term cardiac event was defined as a composite of death and ACS. Baseline characteristics in 2 groups were similar. AP was associated with higher TIMI frame count immediately after the first balloon inflation. After thrombectomy and intracoronary drug administration, final TIMI frame count became similar between AP and non-AP group. Although AP was associated with higher incidence of fatal arrhythmia during hospitalization, in-hospital mortality did not differ between the 2 groups. During follow-up (median 6.2 years), cardiac event-free survival did not differ between the 2 groups. Despite the initial unfavorable effect on coronary reflow, presence of AP did not affect acute as well as long-term clinical outcome in patients with ACS.

Indexed as

Acute Coronary SyndromeAgedAngioplasty, Balloon, CoronaryAspirinCoronary AngiographyCoronary CirculationDisease-Free SurvivalFemaleHospital MortalityHumansJapanKaplan-Meier EstimateMaleMiddle AgedPlaque, AtheroscleroticPlatelet Aggregation InhibitorsAspirinPlatelet Aggregation InhibitorsAcute coronary syndromeAtherosclerosisIVUSStent

Identifiers

PMID25183306
OpenAlexW2053384531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.